{"id":"standard-of-care-part-1","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a regulatory/clinical designation rather than a discrete pharmaceutical agent. 'Standard of Care' denotes the accepted medical treatment baseline against which investigational drugs are typically compared in clinical trials. Part 1 likely refers to an initial phase or component of a multi-part trial design used by CalciMedica.","oneSentence":"Standard of Care (Part 1) refers to the established first-line treatment protocol for a given condition, which varies by indication and is not a specific drug entity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:09:26.957Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05139017","phase":"PHASE2, PHASE3","title":"A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2022-01-14","conditions":"DLBCL, Diffuse Large B-Cell Lymphoma","enrollment":290},{"nctId":"NCT06819176","phase":"PHASE1","title":"Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-01-20","conditions":"Human Immunodeficiency Virus","enrollment":50},{"nctId":"NCT06824467","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-09","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer","enrollment":770},{"nctId":"NCT07424547","phase":"PHASE1","title":"Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Conjupro Biotherapeutics, Inc.","startDate":"2026-03-03","conditions":"Cancer, Solid Tumor Cancer, Advanced Metastatic Cancer","enrollment":386},{"nctId":"NCT07270068","phase":"NA","title":"Remission of Diabetes With Lifestyle Intervention for Malaysian Patients","status":"RECRUITING","sponsor":"Winnie Chee Siew Swee","startDate":"2025-12-16","conditions":"Type 2 Diabetes, Obesity","enrollment":92},{"nctId":"NCT04633252","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-02-23","conditions":"Cancer Of Prostate, Prostate Neoplasms","enrollment":86},{"nctId":"NCT06628310","phase":"PHASE2","title":"A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-12-13","conditions":"Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma","enrollment":180},{"nctId":"NCT07074756","phase":"NA","title":"A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-09-12","conditions":"Glioma, Recurrent Glioma","enrollment":120},{"nctId":"NCT07293715","phase":"PHASE4","title":"Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2026-02-25","conditions":"Pregnancy, High Risk, Type 1 Diabetes","enrollment":44},{"nctId":"NCT07361874","phase":"NA","title":"IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-03-05","conditions":"Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's","enrollment":75},{"nctId":"NCT07498725","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"LARKSPUR BIOSCIENCES, INC.","startDate":"2026-05","conditions":"Neoplasms","enrollment":120},{"nctId":"NCT07491874","phase":"NA","title":"Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage Removal- A Multicenter Randomized Controlled Study","status":"NOT_YET_RECRUITING","sponsor":"Kaplan Medical Center","startDate":"2026-05-01","conditions":"Preterm Delivery, Cervical Cerclage, Cervical Insufficiency","enrollment":60},{"nctId":"NCT02362750","phase":"","title":"Evaluating Cancer Survivorship Care Models","status":"COMPLETED","sponsor":"George Washington University","startDate":"2013-07","conditions":"Quality of Life, Cancer","enrollment":991},{"nctId":"NCT07311512","phase":"NA","title":"PMPR and Chlorhexidine on Periodontal Disease and Vascular Function","status":"RECRUITING","sponsor":"Mahdi Mutahar","startDate":"2026-01-23","conditions":"Periodontal Disease (PD), Cardio Vascular Disease, Oral-Systemic Link","enrollment":30},{"nctId":"NCT07457281","phase":"PHASE1","title":"GV20-0251 and Sintilimab for Neoadjuvant Treatment of Resectable Head and Neck Squamous Cell Carcinoma: A Single-Arm Study","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-04-01","conditions":"Head and Neck Squamous Cell Carcinoma HNSCC","enrollment":9},{"nctId":"NCT05993442","phase":"NA","title":"Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.","status":"RECRUITING","sponsor":"PENTA Foundation","startDate":"2024-05-28","conditions":"Infection, Bacterial, Infection Prevention","enrollment":3080},{"nctId":"NCT07201636","phase":"NA","title":"Natural History Study for Patients With Nemaline Myopathy in Belgium","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2026-08","conditions":"Nemaline Myopathy","enrollment":10},{"nctId":"NCT02211768","phase":"PHASE1","title":"Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-12-08","conditions":"Neurofibromatosis, MPNST","enrollment":10},{"nctId":"NCT05142605","phase":"NA","title":"Evaluation of Grief Therapy Approaches for Bereaved Parents","status":"RECRUITING","sponsor":"University of Miami","startDate":"2022-03-31","conditions":"Grief, Bereavement, Cancer","enrollment":415},{"nctId":"NCT07490301","phase":"PHASE2, PHASE3","title":"A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"AbbVie","startDate":"2026-06-03","conditions":"Metastatic Pancreatic Ductal Adenocarcinoma, PDAC","enrollment":900},{"nctId":"NCT07489508","phase":"","title":"Retrospective Comparison of Tubular Decompression ± Rhizotomy Versus TLIF in Lumbar Spinal Stenosis","status":"COMPLETED","sponsor":"University of Valencia","startDate":"2000-01-01","conditions":"Lumbar Spinal Stenosis, Degenerative Lumbar Spondylolisthesis, Neurogenic Claudication","enrollment":246},{"nctId":"NCT07479381","phase":"","title":"Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study","status":"RECRUITING","sponsor":"Harbinger Health","startDate":"2026-03-20","conditions":"Colorectal Cancer (Diagnosis)","enrollment":1450},{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT06890598","phase":"PHASE3","title":"Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-03-27","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":700},{"nctId":"NCT06949813","phase":"NA","title":"Preventing Maternal Mood, Anxiety, and Trauma Symptoms After Cesarean Delivery","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2025-10-13","conditions":"Anxiety in Pregnancy, Mood Disorder Due to Specified Medical Condition","enrollment":80},{"nctId":"NCT07489066","phase":"PHASE2","title":"Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Pfizer","startDate":"2026-04-01","conditions":"Carcinoma, Non-Small-Cell Lung, Lung Cancer (NSCLC)","enrollment":120},{"nctId":"NCT04704648","phase":"NA","title":"Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa","status":"RECRUITING","sponsor":"AIDS Malignancy Consortium","startDate":"2023-06-21","conditions":"Ocular Surface Squamous Neoplasia, HPV","enrollment":84},{"nctId":"NCT07005102","phase":"PHASE2, PHASE3","title":"A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-08-03","conditions":"Non-Squamous Non-Small Cell Lung Cancer","enrollment":854},{"nctId":"NCT04742634","phase":"PHASE1, PHASE2","title":"Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2022-05-12","conditions":"Myelodysplastic Syndromes","enrollment":209},{"nctId":"NCT05612048","phase":"NA","title":"A Study of Tooth Erosion in People With Esophagogastric Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-11-03","conditions":"Esophagogastric Cancer","enrollment":174},{"nctId":"NCT02503423","phase":"PHASE1, PHASE2","title":"Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas","status":"ACTIVE_NOT_RECRUITING","sponsor":"Taiho Oncology, Inc.","startDate":"2015-07-14","conditions":"Solid Tumors, Lymphoma","enrollment":253},{"nctId":"NCT07227597","phase":"PHASE1, PHASE2","title":"A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-29","conditions":"Small Cell Lung Cancer Extensive Stage","enrollment":170},{"nctId":"NCT07486089","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-02","conditions":"Breast Cancer (Locally Advanced or Metastatic), HER2-positive Breast Cancer, Triple-Negative Breast Cancer (TNBC)","enrollment":60},{"nctId":"NCT07216703","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-19","conditions":"Cervical Cancer","enrollment":1023},{"nctId":"NCT06896695","phase":"NA","title":"A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2025-09-23","conditions":"Head and Neck Carcinoma","enrollment":50},{"nctId":"NCT05268289","phase":"PHASE2","title":"Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-10","conditions":"Lupus Nephritis","enrollment":240},{"nctId":"NCT05606042","phase":"","title":"Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Evaluation","status":"TERMINATED","sponsor":"CurvaFix, Inc.","startDate":"2021-11-24","conditions":"Pelvic Ring Fracture, Acetabular Fracture, Pelvic Fracture","enrollment":53},{"nctId":"NCT07398677","phase":"NA","title":"SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation for Children Undergoing Cancer Treatment","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-02-20","conditions":"School Attendance, Academic Level, Childhood Cancer Survivors","enrollment":128},{"nctId":"NCT06817408","phase":"","title":"Dynamics of Organ Damage and Immune Exhaustion During Sepsis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-03-25","conditions":"Sepsis","enrollment":1000},{"nctId":"NCT07222761","phase":"PHASE3","title":"A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-01-02","conditions":"Relapsed and/or Refractory Multiple Myeloma (RRMM)","enrollment":915},{"nctId":"NCT02789228","phase":"PHASE1","title":"Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's National Research Institute","startDate":"2016-10-12","conditions":"Solid Tumors","enrollment":28},{"nctId":"NCT05128032","phase":"NA","title":"Pressure-enabled Delivery in Radioembolization (TriNav Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-03-01","conditions":"Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer","enrollment":20},{"nctId":"NCT04016142","phase":"PHASE2","title":"Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer","status":"TERMINATED","sponsor":"Centre Oscar Lambret","startDate":"2020-07-15","conditions":"Locally Advanced Cancer, Cervical Cancer","enrollment":21},{"nctId":"NCT05187182","phase":"PHASE1","title":"CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-06-02","conditions":"Gastric Cancer, Esophageal Cancer, Stomach Cancer","enrollment":42},{"nctId":"NCT07469722","phase":"PHASE2, PHASE3","title":"POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2026-03-23","conditions":"Acute Heart Failure (AHF), Congestive Heart Failure Acute, Diuretic Effect","enrollment":128},{"nctId":"NCT05464030","phase":"PHASE1","title":"Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)","status":"RECRUITING","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2022-08-04","conditions":"Colorectal Cancer","enrollment":200},{"nctId":"NCT07161414","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-25","conditions":"Advanced Solid Tumors","enrollment":40},{"nctId":"NCT04943848","phase":"PHASE1","title":"rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG","status":"RECRUITING","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2022-01-10","conditions":"Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant","enrollment":36},{"nctId":"NCT04512235","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-11-03","conditions":"AL Amyloidosis","enrollment":281},{"nctId":"NCT03232931","phase":"NA","title":"Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-10-29","conditions":"Preterm Infant","enrollment":248},{"nctId":"NCT04504825","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-08-25","conditions":"AL Amyloidosis","enrollment":125},{"nctId":"NCT07474558","phase":"PHASE2","title":"SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates","status":"NOT_YET_RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2026-09","conditions":"Advanced or Metastatic Solid Tumour, Antibody-Drug Conjugate, Alopecia","enrollment":102},{"nctId":"NCT01165333","phase":"PHASE1","title":"Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2010-09-06","conditions":"Diffuse Intrinsic Pontine Glioma","enrollment":32},{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT07387354","phase":"PHASE1, PHASE2","title":"Pacritinib With Aza for Upfront Myelodysplastic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2026-05","conditions":"Myelodysplastic Syndromes, MDS, Myelodysplastic Syndrome, Unclassifiable","enrollment":25},{"nctId":"NCT07330999","phase":"NA","title":"Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-02-13","conditions":"Hip Osteoarthritis","enrollment":120},{"nctId":"NCT06299540","phase":"","title":"Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia","status":"RECRUITING","sponsor":"Janssen Cilag S.A.S.","startDate":"2024-05-27","conditions":"Leukemia, Lymphocytic, Chronic, B-Cell","enrollment":180},{"nctId":"NCT06841055","phase":"PHASE2","title":"Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2025-03-03","conditions":"Non-small Cell Lung Cancer","enrollment":60},{"nctId":"NCT07173504","phase":"NA","title":"The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Critically Ill Patients","status":"RECRUITING","sponsor":"Gelderse Vallei Hospital","startDate":"2025-09-30","conditions":"Critical Illness","enrollment":124},{"nctId":"NCT07471607","phase":"NA","title":"Safety and Effectiveness of Overripe Banana Powder Added to Diabetic Formulas in Type 2 Diabetes","status":"COMPLETED","sponsor":"Universiti Sains Malaysia","startDate":"2025-03-01","conditions":"Type 2 Diabetes, Metabolic Disorders","enrollment":60},{"nctId":"NCT06016738","phase":"PHASE3","title":"OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer","status":"RECRUITING","sponsor":"Olema Pharmaceuticals, Inc.","startDate":"2023-11-16","conditions":"Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer","enrollment":510},{"nctId":"NCT07456345","phase":"NA","title":"Evaluation of the Impact of Preoperative Pelvic Floor Exercise on Incontinence After Laser Enucleation of the Prostate: a Feasibility Study.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2024-04-29","conditions":"BPH (Benign Prostatic Hyperplasia), Incontinence, Urinary, HoLEP","enrollment":30},{"nctId":"NCT07466199","phase":"PHASE4","title":"Exogenous Progesterone as Ovulation Trigger","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2026-04","conditions":"Ovulation, Ovarian Function, Assisted Reproductive Treatments","enrollment":10},{"nctId":"NCT07463599","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma","status":"RECRUITING","sponsor":"HonorHealth Research Institute","startDate":"2026-02-17","conditions":"Metastatic Colorectal Carcinoma (mCRC), Colorectal Cancer (CRC), Adenomatous Polyposis Coli (APC) Gene Mutation","enrollment":126},{"nctId":"NCT05996471","phase":"PHASE2","title":"A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2023-08-17","conditions":"HIV Infections","enrollment":185},{"nctId":"NCT07465159","phase":"NA","title":"Multimodal Prehabilitation of Frail Patients Undergoing Elective Knee or Hip Replacement","status":"NOT_YET_RECRUITING","sponsor":"University of Iceland","startDate":"2026-04-01","conditions":"Frailty Syndrome, Prehabilitation, Arthroplasties, Knee Replacement","enrollment":50},{"nctId":"NCT05239741","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2022-04-02","conditions":"Colorectal Neoplasms","enrollment":100},{"nctId":"NCT06726408","phase":"","title":"Critical Care Optimized Pediatric and Neonatal Quantitative Neuromonitoring","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-09-16","conditions":"Neonatal Intensive Care Unit","enrollment":120},{"nctId":"NCT07000149","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2025-07-28","conditions":"Advanced Clear Cell Renal Cell Carcinoma","enrollment":1116},{"nctId":"NCT03523702","phase":"PHASE2","title":"The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-08-30","conditions":"Non-small Cell Lung Cancer, NSCLC","enrollment":25},{"nctId":"NCT06151223","phase":"","title":"A Prospective Registry for Patients at High-Risk for Pancreatic Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-07-13","conditions":"Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC","enrollment":5000},{"nctId":"NCT07057466","phase":"","title":"Prospective Evaluation of AI-ECG for SHD Detection","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2025-11-04","conditions":"Valvular Heart Disease Stenosis and Regurgitation (Diagnosis), Pulmonary Hypertension (Diagnosis), Heart Failure With Reduced Ejection Fraction (HFrEF; Diagnosis)","enrollment":590},{"nctId":"NCT06466395","phase":"PHASE1","title":"A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-02-18","conditions":"Refractory Acute Leukemia, Relapsed Acute Leukemia, Undifferentiated Leukemia","enrollment":22},{"nctId":"NCT06694805","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1","status":"RECRUITING","sponsor":"ViiV Healthcare","startDate":"2024-12-02","conditions":"HIV Infections","enrollment":332},{"nctId":"NCT07456917","phase":"NA","title":"Effects of BREA and MFT Expansion Appliances on Upper Airway Dimensions","status":"COMPLETED","sponsor":"Medical University of Silesia","startDate":"2020-02-01","conditions":"Maxillary Constriction in Growing Children, Transverse Maxillary Deficiency, Upper Airway Morphology in Children","enrollment":79},{"nctId":"NCT07454629","phase":"","title":"BIS Variability and Change in Quality of Recovery After Surgery","status":"RECRUITING","sponsor":"Sakarya University","startDate":"2026-01-01","conditions":"Bispectral Index Variability During General Anesthesia and Postoperative Recovery, Cholecystectomy, Laparoscopic","enrollment":126},{"nctId":"NCT07411989","phase":"NA","title":"Shape-sensing Versus Electromagnetic Robotic Bronchoscopy for Evaluation of PulmoNary LEsions","status":"NOT_YET_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2026-03","conditions":"Peripheral Pulmonary Lesions (PPLs), Lung Nodules","enrollment":346},{"nctId":"NCT07455630","phase":"","title":"Cardiac Function and Biomarkers in Patients With Obesity and Overweight","status":"COMPLETED","sponsor":"TecSalud Investigación Clínica","startDate":"2023-06-20","conditions":"Obesity & Overweight","enrollment":30},{"nctId":"NCT07237191","phase":"NA","title":"Geriatric Distal Femur","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-06","conditions":"Articular Fractures","enrollment":256},{"nctId":"NCT05840315","phase":"NA","title":"Feasibility of High Density Sit-to-stand Functional Resistance Training in Patients With Hip Fracture","status":"COMPLETED","sponsor":"Horsholm Municipality","startDate":"2023-03-21","conditions":"Hip Fractures, Sarcopenia, Fall Injury","enrollment":30},{"nctId":"NCT07454096","phase":"PHASE4","title":"Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2026-04-30","conditions":"Cardiac Disease, Device Related Infection","enrollment":200},{"nctId":"NCT06661356","phase":"NA","title":"Peer-led Community-based PrEP Delivery Among Youth in Brazil","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-10","conditions":"Pre-Exposure Prophylaxis (PrEP), HIV","enrollment":1400},{"nctId":"NCT06762392","phase":"NA","title":"Effectiveness of Blood Flow Restriction in Postoperative Rehabilitation for Anterior Cruciate Ligament Injuries. A Pilot Study.","status":"RECRUITING","sponsor":"University of Valencia","startDate":"2025-01-01","conditions":"Anterior Cruciate Ligament Reconstruction Rehabilitation","enrollment":40},{"nctId":"NCT03033992","phase":"NA","title":"Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-04-04","conditions":"Malignant Glioma, Ependymoma, Diffuse Intrinsic Pontine Glioma","enrollment":80},{"nctId":"NCT02259413","phase":"NA","title":"Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2015-05","conditions":"End-stage Renal Disease, Renal Failure Chronic Requiring Hemodialysis","enrollment":133},{"nctId":"NCT03313778","phase":"PHASE1","title":"Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2017-08-14","conditions":"Solid Tumors","enrollment":161},{"nctId":"NCT06654661","phase":"NA","title":"Utilization of a 3D Printed Mechanical Balancer During Total Knee Arthroplasty (TKA)","status":"NOT_YET_RECRUITING","sponsor":"NYU Langone Health","startDate":"2026-06-01","conditions":"Total Knee Arthroplasty","enrollment":50},{"nctId":"NCT07437820","phase":"NA","title":"Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases","status":"NOT_YET_RECRUITING","sponsor":"GCS Ramsay Santé pour l'Enseignement et la Recherche","startDate":"2026-04","conditions":"Brain Metastases, Adult","enrollment":68},{"nctId":"NCT04857528","phase":"","title":"Detecting HPV DNA in Anal and Cervical Cancers","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2020-10-06","conditions":"Cervical Cancer, Anal Cancer, HPV-Related Anal Squamous Cell Carcinoma","enrollment":20},{"nctId":"NCT07231445","phase":"PHASE1","title":"Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","startDate":"2026-03","conditions":"Small Cell Lung Cancer","enrollment":100},{"nctId":"NCT07223190","phase":"PHASE3","title":"A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia","status":"NOT_YET_RECRUITING","sponsor":"Amgen","startDate":"2026-06-11","conditions":"Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia","enrollment":560},{"nctId":"NCT06042413","phase":"NA","title":"Prediction and Prevention of Postoperative Mortality and Morbidity","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-03","conditions":"Dementia, Postoperative Delirium (POD), Postoperative Neurocognitive Disorder","enrollment":1200},{"nctId":"NCT03442465","phase":"","title":"Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-02-14","conditions":"Bone Sarcoma, Osteosarcoma, Chondrosarcoma","enrollment":300},{"nctId":"NCT05789589","phase":"PHASE1, PHASE2","title":"Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2023-11-17","conditions":"Cancer, Metastasis, Metastatic Cancer","enrollment":46},{"nctId":"NCT07115056","phase":"PHASE4","title":"Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction","status":"WITHDRAWN","sponsor":"Campbell Clinic","startDate":"2026-04-01","conditions":"ACL Injury, ACL Tears, ACL Surgery","enrollment":""},{"nctId":"NCT05681195","phase":"PHASE2","title":"Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2024-04-25","conditions":"Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Relapsed Cancer","enrollment":15},{"nctId":"NCT02476812","phase":"NA","title":"The Positive Piggy Bank - A Positive Activities Intervention for Improving Functional Status in Patients With Back Pain","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2015-06","conditions":"Low Back Pain","enrollment":200},{"nctId":"NCT07206056","phase":"PHASE1, PHASE2","title":"An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-10-15","conditions":"Progressive Metastatic Castrate Resistant Prostate Cancer","enrollment":188},{"nctId":"NCT06896474","phase":"NA","title":"SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2026-02-04","conditions":"Breast Cancer","enrollment":402},{"nctId":"NCT06071858","phase":"NA","title":"Enhanced Coordinated Specialty Care for Early Psychosis","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-02-01","conditions":"Psychosis, Schizophrenia, Schizoaffective Disorder","enrollment":350}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":18,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo-Injectable Emulsion","Sinemet"],"phase":"marketed","status":"active","brandName":"Standard of Care (Part 1)","genericName":"Standard of Care (Part 1)","companyName":"CalciMedica, Inc.","companyId":"calcimedica-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}